ONDCP Seal
Skip NavigationPublicationsPublications
Start of Main Content
The National Methamphetamine
Drug Conference

Conference Proceedings

Table of Contents



Acknowledgments

Conference Summary

Conference Presentations

  1. Opening Remarks

  2. Plenary Presentations

  3. Keynote Addresses

  4. Workgroup Summary Reports

  5. Medical Panel Discussion—Perspectives from Physicians

    • Hoover Adger, M.D., ONDCP Deputy Director, Moderator
    • Everett Ellinwood, M.D., Duke University Medical Center
    • Tom Leland, M.D., Community Care Services, Honolulu, Hawaii
    • Scott Lukas, Ph.D., Harvard Medical School
    • Richard Rawson, Ph.D., the Matrix Institute, Los Angeles, California
    • Michael Sise, M.D., Mercy Hospital, San Diego, California

  6. Closing Remarks

Appendices

Conference Agenda

Workgroup Briefings (in order of presentation)

Workgroup 1: Prevention

  • Gabriel Georges Nahas, M.D., Ph.D., New York University Medical Center
  • Eve Bachrach, J.D., Nonprescription Drug Manufacturers Association
  • Jim Kielley, Warner-Lambert
  • Leslie Bloom, Partnership for a Drug-Free America
  • David Hatcher, Hatcher and Associates
  • Discussion

Workgroup 2: Education

  • David Walker, North Carolina Partnership for Children
  • William Alden, D.A.R.E. America
  • Dick Palmquist and Karen Walklin, Nebraska Broadcasters Association
  • Cathy Siders, Ph.D., Psychologist
  • Discussion

Workgroup 3: Treatment

  • Michael Sise, M.D., Mercy Hospital
  • Richard Rawson, Ph.D., The Matrix Institute
  • Rebecca Games, Games and Associates
  • Discussion

Workgroup 4: Clandestine Labs

  • George J. Doane, California Bureau of Narcotic Enforcement
  • Scott Lukas, Ph.D., Harvard Medical School
  • Karl Palmer, California Department of Toxic Substance Control
  • Terry Brubaker, U.S. Environmental Protection Agency, Region 9
  • Discussion

Workgroup 5: Drug Courts

  • Judge Richard Shull, Municipal Court, Wichita, Kansas
  • Tom Leland, M.D., Community Care Services
  • Alice Huber, Ph.D., the Matrix Institute
  • Judge James Livingston, District Judge, Grand Island, Nebraska
  • Larry Ferrell, J.D., Assistant U.S. Attorney, Missouri
  • Discussion

Workgroup 6: Precursor Chemical Control

  • Walter Ling, M.D., The Matrix Institute
  • Harry Matz, J.D., U.S. Department of Justice
  • Edward Machado, California Bureau of Narcotic Enforcement
  • William Wolf, U.S. Drug Enforcement Administration
  • Discussion
Program Committee